MedTrace Logo

Transgender and Gender Diverse Individuals Screening for Breast Cancer

NCT06347393 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1600

Last updated 2025-03-13

No results posted yet for this study

Summary

The goal of this multicentric prospective study is to evaluate the incidence of Breast Cancer in transgender and gender-diverse population.

Conditions

Interventions

DIAGNOSTIC_TEST

Mammography and Breast Ultrasound

Patients will be scanned using mammography and Breast Ultrasound for Breast Cancer Screening

Sponsors & Collaborators

  • Istituto Europeo di Oncologia

    collaborator OTHER

  • Luigi Sacco University Hospital

    collaborator OTHER

  • Fatebenefratelli Hospital

    collaborator OTHER

  • Ospedale Policlinico San Martino

    collaborator OTHER

  • Università degli studi di Messina, Messina

    collaborator UNKNOWN

  • IRCCS Azienda Ospedaliero-Universitaria di Bologna

    collaborator OTHER

  • Azienda USL Reggio Emilia - IRCCS

    collaborator OTHER_GOV

  • Federico II University

    collaborator OTHER

  • Azienda Ospedaliero-Universitaria Careggi

    collaborator OTHER

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS

    lead OTHER

Principal Investigators

  • Anna D'Angelo · Fondazione Policlinico Universitario A. Gemelli, IRCCS

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-01
Primary Completion
2025-03-31
Completion
2026-03-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06347393 on ClinicalTrials.gov